Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.10
Delayed Data
As of 10:31am ET
 +0.03 / +2.80%
Today’s Change
0.91
Today|||52-Week Range
1.76
-4.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization13.5K15.5K18.5K18.5K
 
 
 
 
 
 
Operating ExpensesGross Income-13.5K-15.5K-18.5K-18.5K
 
 
 
 
 
General Expenses3.3M1.7M2.6M1.7M
 
 
 
 
 
Research And Development1.4M1.0M1.3M1.0M
 
 
 
 
 
Total Operating Expenses3.3M1.7M2.7M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.3M-1.7M-2.7M-1.7M
 
 
 
 
 
Extraordinary Credit0.003.0K0.000.00
 
 
Extraordinary Charge-5.6K0.00-2.4K-6.9K
 
 
 
 
Interest Expense On Debt8.9K8.9K7.2K3.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.3M-1.7M-2.7M-1.7M
 
 
 
 
 
Net Income-3.3M-1.7M-2.7M-1.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.9M49.2M58.8M60.2M
 
 
 
 
 
Shares To Calculate EPS Diluted42.9M49.2M58.8M60.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.03-$0.05-$0.03
 
 
 
 
 
EPS Diluted-$0.08-$0.03-$0.05-$0.03